A Single-Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Gantenerumab Following Subcutaneous (SC) Administration in Healthy Volunteers
Clinical trial NCT02711423 · COMPLETED
Trial details
- NCT number
- NCT02711423
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-31
- Primary completion
- 2016-09-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.